Prognostic Analysis for Survival After Resections of Localized Primary Cardiac Sarcomas: A Single-Institution Experience

Factors affecting in-hospital mortality and likelihood of undergoing surgical resection in patients with primary cardiac tumors

“…However, previous studies investigating patient characteristics and outcomes of cardiac tumors have been largely restricted to single-center case series [6,11,[20][21][22][23] or multicenter studies with limited study populations or small sample sizes [14,[24][25][26]. In addition, patient data in most of the previous studies were collected for study periods of >10 years.…”

“…Most benign cardiac tumors are curable with complete resection [2,8,10,13], while malignant cardiac tumors are less likely to be completely resected and recur more frequently than benign tumors even after complete resection [20][21][22][23][24]27]. Although small benign tumors may be managed nonsurgically with echocardiographic follow-up, a recent observational study reported an increased risk of cerebrovascular complications and mortality in patients with suspected papillary fibroelastomas who did not undergo surgical resection [28].…”

“…No previous study has examined factors associated with the likelihood of undergoing surgical resection in patients with primary cardiac tumors. Although the prognosis of benign tumors is generally good, malignant tumors, especially cardiac sarcomas, have a rapidly fatal course even after surgery [20][21][22][23][24]27]. It remains unclear which patient factors are associated with poor in-hospital prognosis in patients with primary cardiac tumors.…”

Hyperplastic Cardiac Sarcoma Recurrence

“…Postoperative treatment is dictated by morphology, location, and immunohistochemistries. 75% occur within the left atrium, a positive prognostic factor [ 4 ]. We report a young patient who underwent resection and two repeat resections for two recurrences.…”

Cardiac Tumors

“…The overall prognosis for patients with cardiac tumor depends upon histology [5], chemotherapy, particularly in nonresected patients [7] and resection with adequate tumor margin [8,9]. Radiation is only relevant for the treatment of pulmonary artery sarcomas [10].…”